Updated Jul 16, 2026
AH Equity Partners Bio II, L.L.C. has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $11.75M.
| Role | Insider |
|---|
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-04 | NAUT | Nautilus Biotechnology, Inc. | S — Open-market sale | 384.0K | $2.35 | $902K |
| 2026-06-04 | NAUT | Nautilus Biotechnology, Inc. | S — Open-market sale | 4.62M | $2.35 | $10.85M |
AH Equity Partners Bio II, L.L.C. is a corporate insider — currently tracked as Insider of Nautilus Biotechnology, Inc. (NAUT). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($11.75M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live AH Equity Partners Bio II, L.L.C. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.